Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Cencora has signed a definitive agreement to acquire the retina business of EyeSouth Partners for $1.1 billion. After closing, EyeSouth Partners’ affiliated retina physicians will join Cencora’s Retina Consultants of America (RCA), a physician-centered management services organization.
Cencora expects the acquisition to be slightly accretive, net of financing costs, to its adjusted diluted EPS in the first 12 months after closing. The transaction is subject to customary closing conditions, including regulatory approvals.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026